Aspen Pharmacare Holdings Limited (FRA:LDZA)

Aspen Pharmacare Holdings Cash Flow Statement

Financials in millions ZAR. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	-1,083	4,404	5,228	6,488	4,806
Depreciation & Amortization	1,753	1,628	1,455	1,373	1,265
Other Amortization	336	345	333	340	372
Loss (Gain) From Sale of Assets	22	34	1	-1,212	-165
Asset Writedown & Restructuring Costs	4,806	1,667	1,986	1,573	1,115
Stock-Based Compensation	109	117	135	58	67
Provision & Write-off of Bad Debts	272	11	-	-	-
Other Operating Activities	547	-1,739	-260	-594	-1,299
Change in Accounts Receivable	-773	-104	327	-1,355	348
Change in Inventory	-704	200	-2,701	-2,168	-280
Change in Accounts Payable	-126	-338	-984	871	580
Operating Cash Flow	5,159	6,225	5,520	5,374	6,825
Operating Cash Flow Growth	-17.12%	12.77%	2.72%	-21.26%	-17.37%
Capital Expenditures	-2,576	-3,117	-2,230	-1,963	-2,045
Sale of Property, Plant & Equipment	34	13	5	1,830	38
Cash Acquisitions	-229	-4,350	-626	-2,188	-632
Divestitures	6	945	279	434	-
Sale (Purchase) of Intangibles	-2,451	-2,416	-947	-409	-1,011
Investment in Securities	-	52	38	-	-
Other Investing Activities	-	-595	60	135	13,413
Investing Cash Flow	-5,216	-9,468	-3,421	-2,161	9,763
Long-Term Debt Issued	9,880	13,988	7,939	14,208	14,668
Long-Term Debt Repaid	-8,373	-8,784	-6,768	-15,831	-30,266
Net Debt Issued (Repaid)	1,507	5,204	1,171	-1,623	-15,598
Repurchase of Common Stock	-68	-56	-136	-1,857	-50
Common Dividends Paid	-1,601	-1,525	-1,455	-1,196	-
Financing Cash Flow	-162	3,623	-420	-4,676	-15,648
Foreign Exchange Rate Adjustments	-592	-653	843	479	-602
Net Cash Flow	-811	-273	2,522	-984	338
Free Cash Flow	2,583	3,108	3,290	3,411	4,780
Free Cash Flow Growth	-16.89%	-5.53%	-3.55%	-28.64%	-23.16%
Free Cash Flow Margin	5.96%	6.95%	8.08%	8.83%	12.66%
Free Cash Flow Per Share	5.82	7.00	7.41	7.53	10.47
Cash Interest Paid	1,649	2,227	1,324	765	1,205
Cash Income Tax Paid	1,757	2,149	1,614	1,691	1,630
Levered Free Cash Flow	-177.63	260.5	1,776	-261.63	8,820
Unlevered Free Cash Flow	894.25	1,685	2,628	256.5	9,603
Change in Working Capital	-1,603	-242	-3,358	-2,652	648

Source: S&P Global Market Intelligence. Standard template. Financial Sources.